AVCNF Stock | | | USD 0.20 0.01 4.76% |
Insider
Mba BEcon is CEO CoFounder of Avicanna
Phone | 647 243 5283 |
Web | https://www.avicanna.com |
Avicanna Management Efficiency
The company has return on total asset
(ROA) of
(0.2211) % which means that it has lost $0.2211 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(1.6898) %, meaning that it generated substantial loss on money invested by shareholders. Avicanna's management efficiency ratios could be used to measure how well Avicanna manages its routine affairs as well as how well it operates its assets and liabilities.
Avicanna has accumulated 415.83
K in total debt with debt to equity ratio
(D/E) of 0.31, which is about average as compared to similar companies. Avicanna has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Avicanna until it has trouble settling it off, either with new capital or with free cash flow. So, Avicanna's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Avicanna sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Avicanna to invest in growth at high rates of return. When we think about Avicanna's use of debt, we should always consider it together with cash and equity.
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada. Avicanna operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 124 people. Avicanna [AVCNF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.
Management Performance
Avicanna Leadership Team
Elected by the shareholders, the Avicanna's board of directors comprises two types of representatives: Avicanna inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avicanna. The board's role is to monitor Avicanna's management team and ensure that shareholders' interests are well served. Avicanna's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avicanna's outside directors are responsible for providing unbiased perspectives on the board's policies.
Avicanna Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Avicanna a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Avicanna OTC Stock
Avicanna financial ratios help investors to determine whether Avicanna OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avicanna with respect to the benefits of owning Avicanna security.